Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderick Clifton-Bligh

Showing results (111-120 of 140) with videos related to

Pageof 14
Sort By:
The Journal of Clinical Endocrinology and Metabolism|December 23, 2015
Needle(s) in the Haystack-Synchronous Multifocal Tumor-Induced OsteomalaciaAnand K Annamalai, Krishnaswamy Sampathkumar, Shubhada Kane, et al.
Nature Communications|October 21, 2022
Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironmentMagnus Zethoven, Luciano Martelotto, Andrew Pattison, et al.
Annals of Surgical Oncology|May 23, 2025
Adjuvant External Beam Radiotherapy Reduces Local Recurrence in Poorly Differentiated Thyroid Cancer : A Multicenter Retrospective Cohort Study Describing Outcomes in the Treatment of Resectable Poorly Differentiated Thyroid CancerPascal K C Jonker, Jan H Koetje, John Turchini, et al.
Nature Communications|January 9, 2023
Author Correction: Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironmentMagnus Zethoven, Luciano Martelotto, Andrew Pattison, et al.
Neuroendocrinology|September 1, 2022
Australasian Consensus Statement on the Identification, Prevention, and Management of Hormonal Crises in Patients with Neuroendocrine Neoplasms Undergoing Peptide Receptor Radionuclide TherapyMinmin Li, David L Chan, Gonzalo Tapia Rico, et al.
Nature Reviews. Endocrinology|November 19, 2016
Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas, Rodrigo A Toledo, Nelly Burnichon, et al.
The Journal of Pathology|April 4, 2017
Cousins not twins: intratumoural and intertumoural heterogeneity in syndromic neuroendocrine tumoursAidan Flynn, Trisha Dwight, Diana Benn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2017
Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid CancerXiaopei Shen, Guangwu Zhu, Rengyun Liu, et al.
Osteoarthritis and Cartilage Open|December 8, 2022
Corrigendum to "Exploring translational gaps between basic scientists, clinical researchers, clinicians, and consumers: Proceedings and recommendations arising from the 2020 mine the gap online workshop" [Osteoarthritis Cartilage Open 29 (2021) 100163]Vicky Duong, Kim L Bennell, Roderick Clifton-Bligh, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2019
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinomaKyeong J Kim, Sin G Kim, Jie Tan, et al.
Pageof 14

Showing results (111-120 of 140) with videos related to

Sort By:
Pageof 14
The Journal of Clinical Endocrinology and Metabolism|December 23, 2015
Needle(s) in the Haystack-Synchronous Multifocal Tumor-Induced OsteomalaciaAnand K Annamalai, Krishnaswamy Sampathkumar, Shubhada Kane, et al.
Nature Communications|October 21, 2022
Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironmentMagnus Zethoven, Luciano Martelotto, Andrew Pattison, et al.
Annals of Surgical Oncology|May 23, 2025
Adjuvant External Beam Radiotherapy Reduces Local Recurrence in Poorly Differentiated Thyroid Cancer : A Multicenter Retrospective Cohort Study Describing Outcomes in the Treatment of Resectable Poorly Differentiated Thyroid CancerPascal K C Jonker, Jan H Koetje, John Turchini, et al.
Nature Communications|January 9, 2023
Author Correction: Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironmentMagnus Zethoven, Luciano Martelotto, Andrew Pattison, et al.
Neuroendocrinology|September 1, 2022
Australasian Consensus Statement on the Identification, Prevention, and Management of Hormonal Crises in Patients with Neuroendocrine Neoplasms Undergoing Peptide Receptor Radionuclide TherapyMinmin Li, David L Chan, Gonzalo Tapia Rico, et al.
Nature Reviews. Endocrinology|November 19, 2016
Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas, Rodrigo A Toledo, Nelly Burnichon, et al.
The Journal of Pathology|April 4, 2017
Cousins not twins: intratumoural and intertumoural heterogeneity in syndromic neuroendocrine tumoursAidan Flynn, Trisha Dwight, Diana Benn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2017
Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid CancerXiaopei Shen, Guangwu Zhu, Rengyun Liu, et al.
Osteoarthritis and Cartilage Open|December 8, 2022
Corrigendum to "Exploring translational gaps between basic scientists, clinical researchers, clinicians, and consumers: Proceedings and recommendations arising from the 2020 mine the gap online workshop" [Osteoarthritis Cartilage Open 29 (2021) 100163]Vicky Duong, Kim L Bennell, Roderick Clifton-Bligh, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2019
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinomaKyeong J Kim, Sin G Kim, Jie Tan, et al.
Pageof 14